Total Anti-Infliximab

Total Anti-Infliximab
Detecting the presence of total (free and bound) antibodies against Infliximab in patients being treated with Infliximab for chronic autoimmune and inflammatory conditions.

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Total Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or plasma, and delivering results in 22 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

About Using Reagent

• Sample Types Serum, Plasma
• Reaction Time 22 mins
  
• Detection Range 8-250 AU/mL
  
• Indication Semi-quantitative determination of free and bound antibodies against Infliximab in human serum/plasma
  

Click